PsiQuantum and AMD Expand Partnership on Quantum Computing Infrastructure

Insider Brief

• PsiQuantum and AMD have expanded their strategic partnership to co-design the classical and quantum computing infrastructure required for utility-scale, fault-tolerant quantum systems and hybrid applications.
• The collaboration will extend beyond AMD Versal FPGAs to include Instinct GPUs, EPYC CPUs and the ROCm software stack, alongside PsiQuantum’s silicon photonics platform, with AMD also planning an equity investment in PsiQuantum.
• The companies will initially focus on pharmaceutical research and drug discovery, building on work involving GPU-based simulations of covalent inhibitors and a machine-learning decoder designed for real-time error correction.

PRESS RELEASE — PsiQuantum and AMD (NASDAQ: AMD) today announced an expanded strategic partnership to co-design the computing infrastructure required to operate utility-scale, fault-tolerant quantum computers and the hybrid applications that combine quantum, high-performance, and AI computing.

The collaboration builds on the companies’ existing work around AMD Versal™ FPGA technology—selected by PsiQuantum for the development of its fault-tolerant quantum computing platform—and expands it into a broader relationship spanning AMD Instinct™ GPUs, AMD EPYC™ CPUs, and the AMD ROCm™ software stack, combined with PsiQuantum’s silicon photonics platform and its fully integrated platform. As quantum systems scale toward practical use, PsiQuantum and AMD expect the integration of classical high-performance, AI, and photonic quantum computing technology to form the world’s most powerful hybrid computing fabric.

To reinforce its commitment to the partnership, AMD also plans to make an equity investment into PsiQuantum.

“Quantum computing will enable solving problems in healthcare, materials, energy, finance, and other domains that are out of reach today, working in concert with AI and high-performance computing,” said Victor Peng, Chief Executive Officer of PsiQuantum. “By bringing our teams and technologies together, PsiQuantum and AMD will advance the future of computing, from the infrastructure that supports utility-scale quantum systems to new approaches for networking with silicon photonics and scaling the foundations of next-gen AI.”

“AMD has a long track record of bringing together the compute technologies and deep engineering partnerships needed to build the world’s most powerful supercomputers and AI infrastructure,” said Mark Papermaster, Executive Vice President, Chief Technology Officer, AMD. “We see that same opportunity with quantum computing, where leadership in classical computing is essential to building systems at scale. Our work with PsiQuantum brings the breadth of AMD compute and software to this next frontier, combining our strengths to accelerate the path to utility-scale quantum computing.”

The collaboration aligns with the U.S. Department of Energy’s recently released Quantum Genesis Priority Applications, which identify a key set of scientific problems that fault-tolerant quantum computers will be expected to solve.

PsiQuantum’s proprietary computational chemistry methodologies are performing beyond state-of-the-art calculations on AMD hardware today, and the companies’ planned initial focus on drug discovery falls within biological modeling, an identified emerging application area for Quantum Genesis.

By leveraging PsiQuantum’s expertise in workflow and fault-tolerant algorithm development, these methodologies help elevate today’s GPU-based approaches beyond state-of-the-art while preparing critical industries for the arrival of fault-tolerant quantum computing. Working with AMD, PsiQuantum researchers have optimized a highly accurate machine-learning decoder—PRISM—for low-latency implementation on programmable hardware accelerators. The result combines speed and accuracy in a design for real-time error correction in utility-scale photonic quantum computers.

The combination of PsiQuantum’s workflows with AMD’s GPU expertise running large scale simulation has already delivered initial breakthrough results in simulation of covalent inhibitors, a class of molecules relevant in drug discovery for oncology. PsiQuantum plans to build on these results and explore integrated accelerated computing solutions for commercial applications, initially focusing on the broader pharmaceutical research and drug discovery space.

Both companies will also explore expanding their collaboration with a footprint at the Illinois Quantum and Microelectronics Park (IQMP) in Chicago, America’s largest quantum computing project, where PsiQuantum serves as the anchor tenant.

“Illinois is bringing together world-class researchers, a growing list of innovative companies, and a skilled workforce to build the industries of the future,” said Governor JB Pritzker. “AMD and PsiQuantum’s expanded partnership has the potential to advance that work at the Illinois Quantum and Microelectronics Park. Together, we’re laying the foundation to create new opportunities for Illinoisans.”

AMD and PsiQuantum will share more about their strategic partnership at SC26 (November 15-20) in Chicago.